1 of 19

Pediatrics Journal Club Guide

2 of 19

Goals of Journal Club

  • Develop skills in designing studies
  • Practice analyzing an abstract in a structured way
  • Exposure to landmark papers, historical articles, and new literature
  • Participation in discussion!

3 of 19

Expectations for Journal Club

Participants

  • Show up!
  • Participate in small groups
  • Share ideas

Presenters

  • Select article
  • Prepare 6-7 slides to present
    • Research question
    • Causal hypothesis
    • Findings
    • Clinical implications
    • Next study

4 of 19

Structure

  • Presenters work in pairs
  • Each pair of presenters presents 1 paper
  • Ideally 2 groups of participants discuss each research question and develop a proposed study design

8:00 - 8:10

Each pair of presenters presents the brief background and research question being addressed by their paper

8:10 - 8:20

Breakout groups use the template to compose a causal hypothesis. Goal is to develop a study to answer the research question

8:20 - 8:30

Each group presents their study design and answers (~2 min per group)

8:30 - 9:00

Leaders discuss structure of the study. Discussion of differences, strengths, weaknesses, and clinical application

5 of 19

Causal Hypothesis

  • “study purpose” or “causal hypothesis” = the causal relationship that the authors originally intended to study and how they actually studied it

​

  • Identify key aspects of the study design just by reading the abstract
    • Quickly understand the purpose and design of the study
    • Read the rest of the article with focus
    • Critically assess the results within the context of the study design
    • Did the authors adequately study what they intended to?

​

Content adapted from CTS601A, Dr. William Jesdale

6 of 19

Vocabulary

Exposure → Outcome, in Context

​

  • Study design: type of study
  • Exposure: independent variable; the “cause” of what you are studying
  • Exposure Contrast: reference group; compared to what alternative
  • Etiologic Period: when does exposure have an influence on disease, when exposure matters
  • Causal Direction: the impact/effect
  • Outcome: what you are measuring/studying
  • Outcome Contrast: compared to what alternative; “null hypothesis”
  • Population Context: In what population(s) is this relationship expected to be causal?; when, where, and in whom

​

7 of 19

Components of a Causal Hypothesis

Exposure → Outcome, in Context

Conceptual definition: What is the idea? (intention)

Operational realization: How does a given person get assigned an exposure status? An outcome status? Included in study population? (actual)

    • What are the gaps between the conceptual definition and operational definition 🡪 leads to better understanding of the context for interpreting the results of the study
    • Can the results and clinical implications be expanded beyond the context of the study?

​

Content adapted from CTS601A, Dr. William Jesdale

8 of 19

Study Design

(Type of study)

​

Exposure

(Independent variable - the “cause” of what you are studying)

Conceptually:

Operationally:

Exposure Contrast

(Reference group - compared to what alternative)

Conceptually:

Operationally:

Etiologic Period

(Time period of reference)

​

Causal Direction

(Effect)

​

Outcome

(Dependent variable - What you are measuring)

Conceptually:

Operationally:

Outcome Contrast

(“Null hypothesis”)

Conceptually:

Operationally:

Population Context

(Who, when, where)

Conceptually:

Operationally:

9 of 19

Types of Study Designs

  • Meta-Analysis: combining data from many different research studies
  • Systematic Review: A summary of the clinical literature
  • Randomized Controlled Trial: A controlled clinical trial that randomly (by chance) assigns participants to two or more groups
  • Cohort Study (Prospective Observational Study): A clinical research study in which people who presently have a certain condition or receive a particular treatment are followed over time and compared with another group of people who are not affected by the condition
  • Case-control Study: Case-control studies begin with the outcomes and do not follow people over time. Researchers choose people with a particular result (the cases) and interview the groups or check their records to ascertain what different experiences they had
  • Cross-sectional study: Observation of a defined population at a single point in time or time interval. Exposure and outcome are determined simultaneously
  • Case Reports and Series: A report on a series of patients with an outcome of interest. No control group is involved

10 of 19

Cheat Sheet

Study Design

Meta-Analysis, Systematic Review, Randomized Controlled Trial, Cohort Study, Case-control Study, Cross-sectional study,Case Reports and Series

Exposure

“Cause” of what you are studying - medication, intervention, exposure etc.

Exposure Contrast

Compared to what alternative - placebo, unexposed, alternate med/dose, etc.

Etiologic Period

During what time period does the exposure matter - from birth to 2 years, during pregnancy, etc.

Causal Direction

Effect - improves, worsens, increases, decreases, etc.

Outcome

What you are measuring – cancer, happiness, IQ score, etc.

Outcome Contrast

Absence of outcome – no cancer dx, etc

Population Context

Who, when, where - residents in Worcester, MA, etc.

11 of 19

Example of Journal Club Presentation

12 of 19

Background and Research Question

Background: Asthma is a common chronic condition among pediatric patients and is a common cause for presentation to the ED. Short-acting beta(2)-agonists are used to treat asthma symptoms. There are multiple modes of delivery for the medication.

​

​

Research Question: Is breath-enhanced nebulizer effective for treating asthma in pediatrics patients?

13 of 19

Cheat Sheet

Study Design

Meta-Analysis, Systematic Review, Randomized Controlled Trial, Cohort Study, Case-control Study, Cross-sectional study,Case Reports and Series

Exposure

“Cause” of what you are studying - medication, intervention, exposure etc.

Exposure Contrast

Compared to what alternative - placebo, unexposed, alternate med/dose, etc.

Etiologic Period

During what time period does the exposure matter - from birth to 2 years, during pregnancy, etc.

Causal Direction

Effect - improves, worsens, increases, decreases, etc.

Outcome

What you are measuring – cancer, happiness, IQ score, etc.

Outcome Contrast

Absence of outcome – no cancer dx, etc

Population Context

Who, when, where - residents in Worcester, MA, etc.

14 of 19

Abstract

Exposure

​

Etiologic Period

​

Causal Direction

​

Outcome

​

Context

​

15 of 19

Identify components of the causal hypothesis

Study Design

(Type of study)

Randomized control trial

Exposure

(Independent variable - the “cause” of what you are studying)

Conceptually: breath-enhanced nebulizer treatment

Operationally: 5 mg albuterol delivered via breath-enhanced system

Exposure Contrast

(Reference group - compared to what)

Conceptually: conventional jet delivery nebulizer treatment

Operationally: 5 mg albuterol delivered via jet-delivery system

Etiologic Period

(Time period when exposure matters)

Conceptually: during acute asthma exacerbation

Operationally: initial FEV1 <70% of predicted

Causal Direction

(Effect)

increases

Outcome

(Dependent variable - What you are measuring)

Conceptually: change in respiratory function

Operationally: change in FEV1 (missing time frame! – how long after neb?!)

Outcome Contrast

(“Null hypothesis”)

Conceptually: no change in respiratory function

Operationally: no change in FEV1 (missing time frame! – how long after neb?!)

Population Context

(Who, when, where)

Conceptually: children with acute asthma exacerbation in the ED

Operationally: children 8-16 yo with moderate to severe acute asthma who presented to an urban ED during 20-month period from October 2015 to May 2017

16 of 19

Causal Hypothesis

Exposure → Outcome, in Context

​

​

Breath-enhanced delivery of albuterol compared to conventional jet delivery administered during acute asthma exacerbation causes a greater increase in FEV1 among pediatric patients 6-18 years old with a history of moderate to severe asthma while in the Emergency Department

​

​

17 of 19

Results

  • Sample = 107 pediatric patients between 6-18 years old
  • Improvement in FEV1 was significantly greater with conventional jet nebulizer (mean ΔFEV1 +13.8% vs +9.1%, P = .04).
    • Spirometry is effort dependent and challenging to obtain accurate measurements
    • Is a change in FEV1 of 9.1% vs 13.8% CLINICALLY significant?
    • This is an objective outcome, but FEV1 is not used for clinical decision making in the ED
  • There were no significant differences in clinical asthma scores, ED length of stay, disposition, or side effects.
    • These were outcomes of clinical importance for providers in the ED
    • These were secondary outcomes in this study, so they may not have been powered to detect changes, but there was no trend observed either

18 of 19

Clinical Implications

  • Children who received conventional jet nebulizer treatments had statistically significantly more change in FEV1 than those who received breath-enhanced nebulizer treatments.
  • Despite greater change in FEV1, there were not differences in clinical symptoms or length of stay or disposition.

​

  • Based on this study, conventional jet nebulizers deliver albuterol “more effectively” than breath-enhanced nebulizers in pediatric patients
  • Not worth the investment of buying new machines for the pediatric ED to replace conventional jet nebulizers

19 of 19

Next Steps

  • Perform a similar RCT with larger sample size and multiple primary outcomes of clinical importance.

​

  • Perform a similar RCT with DuoNebs instead of albuterol

​

  • Perform a similar RCT, but measure outcome at 20 minutes after neb was completed rather than 10 minutes